CYTOKINETICS INC
▲ 1 upgrades / ▼ 0 downgrades / 2 reiterations from 3 firms
Nov 4, 2026 (8 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Oct 16, 2026 | William Blair | initiate | — → Outperform | — | 48% |
| Oct 8, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 31, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 13, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Aug 13, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Aug 10, 2026 | Truist Securities | maintain | Buy → Buy | — | 55% |
| Aug 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 7, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Aug 7, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jun 29, 2026 | UBS | upgrade | Neutral → Buy | — | 54% |
| Jun 24, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jun 17, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| May 19, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| May 12, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| May 11, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 7, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 6, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| May 6, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| May 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 5, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Apr 10, 2026 | Wells Fargo | initiate | — → Overweight | — | 54% |
| Apr 6, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Mar 18, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Mar 17, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Mar 6, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Feb 26, 2026 | Leerink Partners | maintain | Outperform → Outperform | $84 | 51% |
| Feb 25, 2026 | Citizens | maintain | Market Outperform → Market Outperform | $96 | 47% |
| Feb 25, 2026 | Needham | maintain | Buy → Buy | $85 | 50% |
| Feb 20, 2026 | RBC Capital | maintain | Outperform → Outperform | $101 | 55% |
| Feb 3, 2026 | Truist Securities | maintain | Buy → Buy | $92 | 55% |
| Jan 21, 2026 | B. Riley Securities | maintain | Buy → Buy | $108 | 54% |
| Jan 21, 2026 | RBC Capital | reiterate | Outperform → Outperform | $95 | 55% |
| Jan 20, 2026 | JP Morgan | maintain | Overweight → Overweight | $74 | 55% |
| Dec 23, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $71 | 54% |
| Dec 22, 2025 | RBC Capital | maintain | Outperform → Outperform | $95 | 55% |
| Dec 22, 2025 | Barclays | maintain | Overweight → Overweight | $87 | 53% |
| Dec 22, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $88 | 47% |
| Dec 22, 2025 | Needham | maintain | Buy → Buy | $84 | 50% |
| Dec 22, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $136 | 44% |
| Dec 19, 2025 | Goldman Sachs | upgrade | Neutral → Buy | $95 | 54% |
| Dec 12, 2025 | Needham | reiterate | Buy → Buy | $72 | 50% |
| Nov 11, 2025 | RBC Capital | maintain | Outperform → Outperform | $87 | 55% |
| Nov 10, 2025 | B. Riley Securities | reiterate | Buy → Buy | $90 | 54% |
| Oct 6, 2025 | Barclays | maintain | Overweight → Overweight | $82 | 53% |
| Oct 2, 2025 | B of A Securities | maintain | Neutral → Neutral | $56 | 53% |
| Sep 29, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $120 | 44% |
| Sep 22, 2025 | B. Riley Securities | maintain | Buy → Buy | $80 | 54% |
| Sep 22, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $120 | 44% |
No cross-platform signals in the last 90 days